Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53

Molecular and Cellular Biology

Volumn 20, Issue 21, 2000, Pages 8018-8025

  Lopez, C D ^a   Ao, Y ^a   Rohde, L H ^a   Perez, T D ^a   O'Connor, D J ^a   Lu, X ^a   Ford, J M ^a   Naumovski, L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; PROTEIN P53; PROTEIN P53 INTERACTING PROTEIN 53BP2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; DNA DAMAGE; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; ULTRAVIOLET RADIATION;

APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE; CELL LINE; CELL SURVIVAL; DNA DAMAGE; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ECDYSTERONE; GENOTYPE; MODELS, BIOLOGICAL; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRACYCLINE; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TUBULIN; ULTRAVIOLET RAYS;

EID: 0033782188     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.21.8018-8025.2000     Document Type: Article

References (42)

1. 2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts
2. Mechanisms of p53-mediated apoptosis
3. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
4. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization
5. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
6. Gas1-induced growth suppression requires a transactivation-independent p53 function
7. A matter of life and death
8. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts
9. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance
10. Functions of the MDM2 oncoprotein
11. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2
12. p300/MDM2 complexes participate in MDM2-mediated p53 degradation
13. Mdm2 promotes the rapid degradation of p53
14. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53
15. Mediation of c-Myc-induced apoptosis by p53
16. The ubiquitin system
17. Rb regulates the stability and the apoptotic function of p53 via MDM2
18. Two cellular proteins that bind to wild-type but not mutant p53
19. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2
20. The dual role model for p53 in maintaining genomic integrity
21. Covalent and noncovalent modifiers of the p53 protein
22. Regulation of p53 stability by MDM2
23. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
24. p53: Puzzle and paradigm
25. p53, The cellular gatekeeper for growth and division
26. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
27. Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines
28. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a
29. APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus
30. 2/M
31. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis
32. A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1
33. Nuclear localization of IkBα is mediated by the second ankyrin repeat: The IkBα ankyrin repeats define a novel class of cis-acting nuclear import sequences
34. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2
35. Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells
36. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
37. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1 and 53BP2
38. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1
39. Nucleolar Arf sequesters MDM2 and activates p53
40. NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2
41. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles